Literature DB >> 8242289

Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography.

E Leen1, J A Goldberg, J Robertson, W J Angerson, G R Sutherland, T G Cooke, C S McArdle.   

Abstract

Previous studies have shown that overt intrahepatic tumours are associated with subtle changes in liver perfusion that can be measured directly using duplex colour Doppler sonography (DCDS). This study assessed the predictive value of DCDS in the early detection of occult colorectal hepatic metastases. Hepatic arterial and portal venous blood flow was measured in 50 control subjects and 135 patients with colorectal cancer, 67 with overt liver metastases and 68 with an apparently disease-free liver on the basis of computed tomography and laparotomy findings. The Doppler perfusion index (DPI), defined as the ratio of hepatic arterial to total liver blood flow, was calculated. Clear separation of the DPI values of controls and those of patients with overt metastases was observed (P < 0.0001). Thirty-eight of the 68 patients with a disease-free liver also had an abnormally high DPI value. After 1 year of follow-up, 21 patients with an abnormally high DPI at the time of apparently curative primary resection had developed liver metastases and a further four had died without post-mortem examination. The 30 patients with normal DPI remain disease-free. The data suggest that DPI is of value in the early detection of occult liver metastases.

Entities:  

Mesh:

Year:  1993        PMID: 8242289     DOI: 10.1002/bjs.1800801009

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

Review 1.  Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer.

Authors:  Mario Kopljar; Leonardo Patrlj; Zeljko Bušić; Marijan Kolovrat; Mislav Rakić; Robert Kliček; Marcel Zidak; Igor Stipančić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  A prospective study of six methods for detection of hepatic colorectal metastases.

Authors:  R Carter; D Hemingway; T G Cooke; R Pickard; F W Poon; J A McKillop; C S McArdle
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

Review 3.  Colorectal cancer and the liver.

Authors:  I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1997-09       Impact factor: 1.891

4.  Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Authors:  Y Tsushima; M J Blomley; H Yokoyama; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  Diagnostic value of measuring liver volume for detecting occult hepatic metastases from colorectal or gastric cancer.

Authors:  Takeaki Ishizawa; Tetsuhisa Yamamoto; Koichiro Nishida; Hajime Tsukui; Takayoshi Sekikawa
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

6.  Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: relationship to histological features.

Authors:  K M Walsh; E Leen; R N MacSween; A J Morris
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

7.  Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up results.

Authors:  E Leen; W J Angerson; H Wotherspoon; B Moule; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

8.  Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival.

Authors:  E Leen; W G Angerson; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

9.  Respiratory self-gating for free-breathing abdominal phase-contrast blood flow measurements.

Authors:  Ning Jin; Robert J Lewandowski; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

10.  Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator.

Authors:  R Carter; J H Anderson; T G Cooke; J N Baxter; W J Angerson
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.